Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 41

1.

The p52 isoform of SHC1 is a key driver of breast cancer initiation.

Wright KD, Miller BS, El-Meanawy S, Tsaih SW, Banerjee A, Geurts AM, Sheinin Y, Sun Y, Kalyanaraman B, Rui H, Flister MJ, Sorokin A.

Breast Cancer Res. 2019 Jun 15;21(1):74. doi: 10.1186/s13058-019-1155-7.

2.

Trefoil factor(s) and CA19.9: A promising panel for early detection of pancreatic cancer.

Jahan R, Ganguly K, Smith LM, Atri P, Carmicheal J, Sheinin Y, Rachagani S, Natarajan G, Brand RE, Macha MA, Grandgenett PM, Kaur S, Batra SK.

EBioMedicine. 2019 Apr;42:375-385. doi: 10.1016/j.ebiom.2019.03.056. Epub 2019 Apr 5.

3.

FDPS cooperates with PTEN loss to promote prostate cancer progression through modulation of small GTPases/AKT axis.

Seshacharyulu P, Rachagani S, Muniyan S, Siddiqui JA, Cruz E, Sharma S, Krishnan R, Killips BJ, Sheinin Y, Lele SM, Smith LM, Talmon GA, Ponnusamy MP, Datta K, Batra SK.

Oncogene. 2019 Jun;38(26):5265-5280. doi: 10.1038/s41388-019-0791-9. Epub 2019 Mar 26.

PMID:
30914801
4.

Correction to Tumor-Penetrating Nanoparticles for Enhanced Anticancer Activity of Combined Photodynamic and Hypoxia-Activated Therapy.

Wang Y, Xie Y, Li J, Peng ZH, Sheinin Y, Zhou J, Oupický D.

ACS Nano. 2019 Apr 23;13(4):4855. doi: 10.1021/acsnano.9b01888. Epub 2019 Mar 19. No abstract available.

PMID:
30888139
5.

Pharmacokinetics and efficacy of orally administered polymeric chloroquine as macromolecular drug in the treatment of inflammatory bowel disease.

Kanvinde S, Chhonker YS, Ahmad R, Yu F, Sleightholm R, Tang W, Jaramillo L, Chen Y, Sheinin Y, Li J, Murry DJ, Singh AB, Oupický D.

Acta Biomater. 2018 Dec;82:158-170. doi: 10.1016/j.actbio.2018.10.027. Epub 2018 Oct 17.

PMID:
30342282
6.

Crosstalk between PKCα and PI3K/AKT Signaling Is Tumor Suppressive in the Endometrium.

Hsu AH, Lum MA, Shim KS, Frederick PJ, Morrison CD, Chen B, Lele SM, Sheinin YM, Daikoku T, Dey SK, Leone G, Black AR, Black JD.

Cell Rep. 2018 Jul 17;24(3):655-669. doi: 10.1016/j.celrep.2018.06.067.

7.

Development and characterization of carboxy-terminus specific monoclonal antibodies for understanding MUC16 cleavage in human ovarian cancer.

Aithal A, Junker WM, Kshirsagar P, Das S, Kaur S, Orzechowski C, Gautam SK, Jahan R, Sheinin YM, Lakshmanan I, Ponnusamy MP, Batra SK, Jain M.

PLoS One. 2018 Apr 30;13(4):e0193907. doi: 10.1371/journal.pone.0193907. eCollection 2018.

8.

Loss of the Nuclear Pool of Ubiquitin Ligase CHIP/STUB1 in Breast Cancer Unleashes the MZF1-Cathepsin Pro-oncogenic Program.

Luan H, Mohapatra B, Bielecki TA, Mushtaq I, Mirza S, Jennings TA, Clubb RJ, An W, Ahmed D, El-Ansari R, Storck MD, Mishra NK, Guda C, Sheinin YM, Meza JL, Raja S, Rakha EA, Band V, Band H.

Cancer Res. 2018 May 15;78(10):2524-2535. doi: 10.1158/0008-5472.CAN-16-2140. Epub 2018 Mar 6.

9.

Tumor-Penetrating Nanoparticles for Enhanced Anticancer Activity of Combined Photodynamic and Hypoxia-Activated Therapy.

Wang Y, Xie Y, Li J, Peng ZH, Sheinin Y, Zhou J, Oupický D.

ACS Nano. 2017 Feb 28;11(2):2227-2238. doi: 10.1021/acsnano.6b08731. Epub 2017 Feb 6. Erratum in: ACS Nano. 2019 Apr 23;13(4):4855.

10.

hPaf1/PD2 interacts with OCT3/4 to promote self-renewal of ovarian cancer stem cells.

Karmakar S, Seshacharyulu P, Lakshmanan I, Vaz AP, Chugh S, Sheinin YM, Mahapatra S, Batra SK, Ponnusamy MP.

Oncotarget. 2017 Feb 28;8(9):14806-14820. doi: 10.18632/oncotarget.14775.

11.

Mucins and associated O-glycans based immunoprofile for stratification of colorectal polyps: clinical implication for improved colon surveillance.

Krishn SR, Kaur S, Sheinin YM, Smith LM, Gautam SK, Patel A, Jain M, Juvvigunta V, Pai P, Lazenby AJ, Roy HK, Batra SK.

Oncotarget. 2017 Jan 24;8(4):7025-7038. doi: 10.18632/oncotarget.12347.

12.

MUC4 is negatively regulated through the Wnt/β-catenin pathway via the Notch effector Hath1 in colorectal cancer.

Pai P, Rachagani S, Dhawan P, Sheinin YM, Macha MA, Qazi AK, Chugh S, Ponnusamy MP, Mallya K, Pothuraju R, Batra SK.

Genes Cancer. 2016 May;7(5-6):154-168. doi: 10.18632/genesandcancer.108.

13.

A novel CBL-Bflox/flox mouse model allows tissue-selective fully conditional CBL/CBL-B double-knockout: CD4-Cre mediated CBL/CBL-B deletion occurs in both T-cells and hematopoietic stem cells.

Goetz B, An W, Mohapatra B, Zutshi N, Iseka F, Storck MD, Meza J, Sheinin Y, Band V, Band H.

Oncotarget. 2016 Aug 9;7(32):51107-51123. doi: 10.18632/oncotarget.9812.

14.

Loss of N-acetylgalactosaminyltransferase 3 in poorly differentiated pancreatic cancer: augmented aggressiveness and aberrant ErbB family glycosylation.

Chugh S, Meza J, Sheinin YM, Ponnusamy MP, Batra SK.

Br J Cancer. 2016 Jun 14;114(12):1376-86. doi: 10.1038/bjc.2016.116. Epub 2016 May 17.

15.

RAC1 GTPase promotes the survival of breast cancer cells in response to hyper-fractionated radiation treatment.

Hein AL, Post CM, Sheinin YM, Lakshmanan I, Natarajan A, Enke CA, Batra SK, Ouellette MM, Yan Y.

Oncogene. 2016 Dec 8;35(49):6319-6329. doi: 10.1038/onc.2016.163. Epub 2016 May 16.

16.

PR55α Subunit of Protein Phosphatase 2A Supports the Tumorigenic and Metastatic Potential of Pancreatic Cancer Cells by Sustaining Hyperactive Oncogenic Signaling.

Hein AL, Seshacharyulu P, Rachagani S, Sheinin YM, Ouellette MM, Ponnusamy MP, Mumby MC, Batra SK, Yan Y.

Cancer Res. 2016 Apr 15;76(8):2243-2253. doi: 10.1158/0008-5472.CAN-15-2119. Epub 2016 Feb 18.

17.

The canonical Wnt pathway regulates the metastasis-promoting mucin MUC4 in pancreatic ductal adenocarcinoma.

Pai P, Rachagani S, Lakshmanan I, Macha MA, Sheinin Y, Smith LM, Ponnusamy MP, Batra SK.

Mol Oncol. 2016 Feb;10(2):224-39. doi: 10.1016/j.molonc.2015.10.005. Epub 2015 Oct 19.

18.

Mice deficient in Muc4 are resistant to experimental colitis and colitis-associated colorectal cancer.

Das S, Rachagani S, Sheinin Y, Smith LM, Gurumurthy CB, Roy HK, Batra SK.

Oncogene. 2016 May 19;35(20):2645-54. doi: 10.1038/onc.2015.327. Epub 2015 Sep 14.

19.

Amyloid precursor-like protein 2 (APLP2) affects the actin cytoskeleton and increases pancreatic cancer growth and metastasis.

Pandey P, Rachagani S, Das S, Seshacharyulu P, Sheinin Y, Naslavsky N, Pan Z, Smith BL, Peters HL, Radhakrishnan P, McKenna NR, Giridharan SS, Haridas D, Kaur S, Hollingsworth MA, MacDonald RG, Meza JL, Caplan S, Batra SK, Solheim JC.

Oncotarget. 2015 Feb 10;6(4):2064-75.

20.

B7-H1 expression in malignant pleural mesothelioma is associated with sarcomatoid histology and poor prognosis.

Mansfield AS, Roden AC, Peikert T, Sheinin YM, Harrington SM, Krco CJ, Dong H, Kwon ED.

J Thorac Oncol. 2014 Jul;9(7):1036-40. doi: 10.1097/JTO.0000000000000177.

21.

Tissue microarrays: one size does not fit all.

Eckel-Passow JE, Lohse CM, Sheinin Y, Crispen PL, Krco CJ, Kwon ED.

Diagn Pathol. 2010 Jul 7;5:48. doi: 10.1186/1746-1596-5-48.

22.

Evaluation of B7-H3 expression as a biomarker of biochemical recurrence after salvage radiation therapy for recurrent prostate cancer.

Parker AS, Heckman MG, Sheinin Y, Wu KJ, Hilton TW, Diehl NN, Pisansky TM, Schild SE, Kwon ED, Buskirk SJ.

Int J Radiat Oncol Biol Phys. 2011 Apr 1;79(5):1343-9. doi: 10.1016/j.ijrobp.2010.01.061. Epub 2010 Jul 2.

PMID:
20598810
23.

T-cell co-regulatory molecule expression in renal angiomyolipoma and pulmonary lymphangioleiomyomatosis.

Boorjian SA, Sheinin Y, Crispen PL, Lohse CM, Leibovich BC, Kwon ED.

Urology. 2009 Dec;74(6):1359-64. doi: 10.1016/j.urology.2009.03.007. Epub 2009 Jun 7.

24.

Development and evaluation of BioScore: a biomarker panel to enhance prognostic algorithms for clear cell renal cell carcinoma.

Parker AS, Leibovich BC, Lohse CM, Sheinin Y, Kuntz SM, Eckel-Passow JE, Blute ML, Kwon ED.

Cancer. 2009 May 15;115(10):2092-103. doi: 10.1002/cncr.24263.

25.

Expression of immunosuppresive B7-H3 ligand by hormone-treated prostate cancer tumors and metastases.

Chavin G, Sheinin Y, Crispen PL, Boorjian SA, Roth TJ, Rangel L, Blute ML, Sebo TJ, Tindall DJ, Kwon ED, Karnes RJ.

Clin Cancer Res. 2009 Mar 15;15(6):2174-80. doi: 10.1158/1078-0432.CCR-08-2262. Epub 2009 Mar 10.

26.

Sirolimus affects cardiomyocytes to reduce left ventricular mass in heart transplant recipients.

Kushwaha SS, Raichlin E, Sheinin Y, Kremers WK, Chandrasekaran K, Brunn GJ, Platt JL.

Eur Heart J. 2008 Nov;29(22):2742-50. doi: 10.1093/eurheartj/ehn407. Epub 2008 Sep 11.

27.

Tumor cell and tumor vasculature expression of B7-H3 predict survival in clear cell renal cell carcinoma.

Crispen PL, Sheinin Y, Roth TJ, Lohse CM, Kuntz SM, Frigola X, Thompson RH, Boorjian SA, Dong H, Leibovich BC, Blute ML, Kwon ED.

Clin Cancer Res. 2008 Aug 15;14(16):5150-7. doi: 10.1158/1078-0432.CCR-08-0536. Epub 2008 Aug 11.

28.

T-cell coregulatory molecule expression in urothelial cell carcinoma: clinicopathologic correlations and association with survival.

Boorjian SA, Sheinin Y, Crispen PL, Farmer SA, Lohse CM, Kuntz SM, Leibovich BC, Kwon ED, Frank I.

Clin Cancer Res. 2008 Aug 1;14(15):4800-8. doi: 10.1158/1078-0432.CCR-08-0731.

29.

Comparison of digital image analysis versus visual assessment to assess survivin expression as an independent predictor of survival for patients with clear cell renal cell carcinoma.

Parker AS, Lohse CM, Leibovich BC, Cheville JC, Sheinin YM, Kwon ED.

Hum Pathol. 2008 Aug;39(8):1176-84. doi: 10.1016/j.humpath.2007.12.009. Epub 2008 Jun 5.

30.

Hormone receptor expression in renal angiomyolipoma: clinicopathologic correlation.

Boorjian SA, Sheinin Y, Crispen PL, Lohse CM, Kwon ED, Leibovich BC.

Urology. 2008 Oct;72(4):927-32. doi: 10.1016/j.urology.2008.01.067. Epub 2008 Mar 28.

31.

External validation of IMP3 expression as an independent prognostic marker for metastatic progression and death for patients with clear cell renal cell carcinoma.

Hoffmann NE, Sheinin Y, Lohse CM, Parker AS, Leibovich BC, Jiang Z, Kwon ED.

Cancer. 2008 Apr 1;112(7):1471-9. doi: 10.1002/cncr.23296.

32.

Carbonic anhydrase IX is not an independent predictor of outcome for patients with clear cell renal cell carcinoma.

Leibovich BC, Sheinin Y, Lohse CM, Thompson RH, Cheville JC, Zavada J, Kwon ED.

J Clin Oncol. 2007 Oct 20;25(30):4757-64.

PMID:
17947723
33.

B7-H3 ligand expression by prostate cancer: a novel marker of prognosis and potential target for therapy.

Roth TJ, Sheinin Y, Lohse CM, Kuntz SM, Frigola X, Inman BA, Krambeck AE, McKenney ME, Karnes RJ, Blute ML, Cheville JC, Sebo TJ, Kwon ED.

Cancer Res. 2007 Aug 15;67(16):7893-900. Epub 2007 Aug 8.

34.

Ki-67 and coagulative tumor necrosis are independent predictors of poor outcome for patients with clear cell renal cell carcinoma and not surrogates for each other.

Tollefson MK, Thompson RH, Sheinin Y, Lohse CM, Cheville JC, Leibovich BC, Kwon ED.

Cancer. 2007 Aug 15;110(4):783-90.

35.

Induction of chondrocyte growth arrest by FGF: transcriptional and cytoskeletal alterations.

Rozenblatt-Rosen O, Mosonego-Ornan E, Sadot E, Madar-Shapiro L, Sheinin Y, Ginsberg D, Yayon A.

J Cell Sci. 2002 Feb 1;115(Pt 3):553-62.

36.

Protein phosphatase 2Calpha expression in normal human tissues: an immunohistochemical study.

Lifschitz-Mercer B, Sheinin Y, Ben-Meir D, Bramante-Schreiber L, Leider-Trejo L, Karby S, Smorodinsky NI, Lavi S.

Histochem Cell Biol. 2001 Jul;116(1):31-9.

PMID:
11479720
37.
38.

Immunocytochemical localization of the extracellular calcium-sensing receptor in normal and malignant human large intestinal mucosa.

Sheinin Y, Kállay E, Wrba F, Kriwanek S, Peterlik M, Cross HS.

J Histochem Cytochem. 2000 May;48(5):595-602.

PMID:
10769043
39.

Restrained chondrocyte proliferation and maturation with abnormal growth plate vascularization and ossification in human FGFR-3(G380R) transgenic mice.

Segev O, Chumakov I, Nevo Z, Givol D, Madar-Shapiro L, Sheinin Y, Weinreb M, Yayon A.

Hum Mol Genet. 2000 Jan 22;9(2):249-58.

PMID:
10607835
40.

Epidermal growth factor receptor expression in primary cultured human colorectal carcinoma cells.

Tong WM, Ellinger A, Sheinin Y, Cross HS.

Br J Cancer. 1998 Jun;77(11):1792-8.

41.

Establishment of primary cultures from human colonic tissue during tumor progression: vitamin-D responses and vitamin-D-receptor expression.

Tong WM, Bises G, Sheinin Y, Ellinger A, Genser D, Pötzi R, Wrba F, Wenzl E, Roka R, Neuhold N, Peterlik M, Cross HS.

Int J Cancer. 1998 Jan 30;75(3):467-72.

Supplemental Content

Loading ...
Support Center